International Council for Standardization in Haematology
Disclaimer:
Information regarding a non-State actor, contained in the section “Non-State Actors Profiles”
in the Register, has been provided by that non-State actor itself, and the accuracy
and completeness of such information is the sole responsibility of that non-State
actor, not WHO. In turn, information in the sections “WHO’s Engagement” and “Non-State
Actors in Official Relations” has been provided by WHO, subject to certain conditions.
All access and use of any section of the Register is governed by the Terms and Conditions of Use.
Overview
International Council for Standardization in Haematology
ICSH
The International Council for Standardization in Haematology (ICSH) was originally founded as a standardizing committee associated with the European Society of Haematology in 1963. The ICSH has been associated with the International Society for Laboratory Hematology (ISLH) since 2007.
The ICSH is a not-for-profit organisation that aims to achieve reliable and reproducible results in laboratory analysis in the field of diagnostic haematology.
The ICSH coordinates Working Groups of experts to examine laboratory methods and instruments for haematological analyses, to deliberate on issues of standardization and to stimulate and coordinate scientific work as necessary towards the development of international standardization materials and guidelines
The ICSH is a not-for-profit organisation that aims to achieve reliable and reproducible results in laboratory analysis in the field of diagnostic haematology.
The ICSH coordinates Working Groups of experts to examine laboratory methods and instruments for haematological analyses, to deliberate on issues of standardization and to stimulate and coordinate scientific work as necessary towards the development of international standardization materials and guidelines
http://www.icsh.org
18 Sep 2024 05:32:08 AM
General information
International Council for Standardization in Haematology
ICSH
International Council for Standardization in Haematology
ICSH
The International Council for Standardization in Haematology (ICSH) was originally founded as a standardizing committee associated with the European Society of Haematology in 1963. The ICSH has been associated with the International Society for Laboratory Hematology (ISLH) since 2007.
The ICSH is a not-for-profit organisation that aims to achieve reliable and reproducible results in laboratory analysis in the field of diagnostic haematology.
The ICSH coordinates Working Groups of experts to examine laboratory methods and instruments for haematological analyses, to deliberate on issues of standardization and to stimulate and coordinate scientific work as necessary towards the development of international standardization materials and guidelines
The ICSH is a not-for-profit organisation that aims to achieve reliable and reproducible results in laboratory analysis in the field of diagnostic haematology.
The ICSH coordinates Working Groups of experts to examine laboratory methods and instruments for haematological analyses, to deliberate on issues of standardization and to stimulate and coordinate scientific work as necessary towards the development of international standardization materials and guidelines
2 Packhorse Rd
Gerrards Cross
Buckinghamshire
SL97QE
United Kingdom of Great Britain and Northern Ireland (The)
admin@icsh.org
http://www.icsh.org
Governance
NGO registered in UK
2013
ICSH Board
Prof Wendy Erber
Chair
University of Western Australia and PathWest Laboratory Medicine, Perth, Australia
Prof Gina Zini
WHO Liaison (Ex Officio)
Fondazione Policlinico Universitario A. Gemelli IRCCS - Roma Università Cattolica del Sacro Cuore
Dr Steve Kitchen
Vice Chair Haemostasis
Sheffield Haemophilia and Thrombosis Centre, Sheffield Teaching Hospitals, Sheffield, UK
Dr Ian Mackie
Treasurer
Emeritus Reader in Haemostasis and Thrombosis Research Haematology Dept University College London
Dr Paul Harrison
Board Member
University of Birmingham Medical School, Birmingham, UK
Prof Cornelis Harteveld
Board Member
Leiden University Medical Centre, The Netherlands
Mr Richard McCafferty
Board Member
Department of Haematology, St James’s Hospital, Dublin, Ireland
Prof Amrom Obstfeld
Scientific Secretary
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
Dr Ben Hedley
Board Member
Department of Haematology London Health Services Toronto Canada
Dr Jij-Yeong Han
Board Member
Department of Laboratory Medicine Dong-A University College of Medicine Busan, Korea
Dr Michelle Grant
Board Member
Department of Haematology Geisinger Medical USA
To administer all ICSH activities and set the long term direction including:
Financial Stability
Good corporate governance
Making all guidelines freely available to the global Laboratory Haematology community
Running the annual General Assembly
Financial Stability
Good corporate governance
Making all guidelines freely available to the global Laboratory Haematology community
Running the annual General Assembly
ICSH General Assembly
Up to 60 invited attendees comprising:
ICSH Board Members
ICSH Project Leaders
ICSH Corporate Supporters
ICSH Affiliate Associations and Organizations
Invited Experts
ICSH Board Members
ICSH Project Leaders
ICSH Corporate Supporters
ICSH Affiliate Associations and Organizations
Invited Experts
To update all attendees over two days of the General Assembly (ususally held in October of each year):
ICSH Direction including board decisions and outcomes
Presentations on recently published guidelines
Presentations on guidelines in the pipeline
Presentations on potential new projects and guidelines
Presentations from key stakeholder groups
ICSH Direction including board decisions and outcomes
Presentations on recently published guidelines
Presentations on guidelines in the pipeline
Presentations on potential new projects and guidelines
Presentations from key stakeholder groups
Financial information
January
2023
December
2023
115,000
December
2023
308,000
Private sector entities (including business associations)
Philanthropic foundations
NGOs, academic institutions
Government entities, intergovernmental organizations, including
UN
General public, individuals
Total
671
671
10,000
10,000
105,000
105,000
115,671
115,671
Audited report is in GBP (converted to US$ as requested)
Membership
Individuals
NGOs
Private sector entities
17
Philanthropic foundations
Academic institutions
16
Government entities
Intergovernmental organizations
https://icsh.org/about-us
Organizational Structure
No data available
Registered in the UK as a Charitable Organization - Charity Number 1178359
No data available
Relations
No data available
No data available
Activities
Promoting development of international standards required to achieve
international comparability of results of laboratory tests;
Promoting improvements of methods and standards by establishing
expert panels with internationally respected authoritative members
Maintaining a forum of communication amongst various professional
organizations concerned with various aspects of diagnostic
haematology.
In this context the term "standards" was defined as:
Specifications for biological and chemical reagents or reference
preparations;
Reference methods or reference procedures;
Systems of nomenclature;
Standard operating procedures amd use of controls and calibrators and
other test procedures;
Quality control and quality assurance.
international comparability of results of laboratory tests;
Promoting improvements of methods and standards by establishing
expert panels with internationally respected authoritative members
Maintaining a forum of communication amongst various professional
organizations concerned with various aspects of diagnostic
haematology.
In this context the term "standards" was defined as:
Specifications for biological and chemical reagents or reference
preparations;
Reference methods or reference procedures;
Systems of nomenclature;
Standard operating procedures amd use of controls and calibrators and
other test procedures;
Quality control and quality assurance.
Strategic objective 1: Respond to climate change, an escalating health threat in the 21st century
Strategic objective 2: Address health determinants and the root causes of ill health in key policies across sectors
Strategic objective 3: Advance the primary health care approach and essential health system capacities for universal health coverage
Strategic objective 4: Improve health service coverage and financial protection to address inequity and gender inequalities
Strategic objective 5: Prevent, mitigate and prepare for risks to health from all hazards
Strategic objective 6: Rapidly detect and sustain an effective response to all health emergencies
The HbA2 standardization project has progressed in the last 12 months up to the point that the two Certified Reference Materials for low value and high value of HbA2 have been produced (3000 ampoules each) by the EU-JRC in Geel, Belgium. The material was sent out to two collaborating metrological laboratories in Germany for value assignment midst 2023, but due to technical problems the value assignment has been postponed until the first half of 2024. The roadmap describing the finishing steps of testing the certified reference material by volunteering labs recruited from ICSH and participants of UKNEQAS assessment scheme for Hb variants, will proceed as described in Clin Chim Acta. 2021 Jan;512:185-190.
The Hemoglobin Hbg Cyanide Standard is used for spectrophotometric Hb determination and expired in March 2023. It has been replaced by a new batch of standard in collaboration with Eurotrol B.V. Wageningen, NL. Six independent laboratories, recruited from ICSH members, have determined the value of the newly produced batch of Hemoglobin Hbg Standard, which was launched in March 2023. The previous batch has expired and is no longer available. A technical report describing the value assignment and production of the new batch of Hbg standard has been submitted to the Int Journal of Laboratory Hematology in December 2023 and accepted for publication in 2024.
In 2023 a joined working group IFCC and ICSH was formed to initiate the standardization of the HbF, following the same procedure as has been developed for the standardization of HbA2. Preparations were started and will proceed in 2024.
ICSH Haemostasis Meeting - June 2023 Montreal Canada - attendance 30 participants to discuss Haemostasis standardization projects
ICSH General Assembly Meeting - October 2023 Singapore -attendance 50 participants to discuss Haematology standardization projects
The Hemoglobin Hbg Cyanide Standard is used for spectrophotometric Hb determination and expired in March 2023. It has been replaced by a new batch of standard in collaboration with Eurotrol B.V. Wageningen, NL. Six independent laboratories, recruited from ICSH members, have determined the value of the newly produced batch of Hemoglobin Hbg Standard, which was launched in March 2023. The previous batch has expired and is no longer available. A technical report describing the value assignment and production of the new batch of Hbg standard has been submitted to the Int Journal of Laboratory Hematology in December 2023 and accepted for publication in 2024.
In 2023 a joined working group IFCC and ICSH was formed to initiate the standardization of the HbF, following the same procedure as has been developed for the standardization of HbA2. Preparations were started and will proceed in 2024.
ICSH Haemostasis Meeting - June 2023 Montreal Canada - attendance 30 participants to discuss Haemostasis standardization projects
ICSH General Assembly Meeting - October 2023 Singapore -attendance 50 participants to discuss Haematology standardization projects
Country presence
Regions
Countries
Activities
Members
Offices / representatives
African Region
Region of the Americas
Eastern Mediterranean Region
European Region
South-East Asia Region
Western Pacific Region
Global
Disclosure & declaration
Pursuant the WHO Framework of Engagement with Non-State Actors, WHO does not engage with the tobacco industry or non-State actors that work to further the interests of the tobacco industry. WHO also does not engage with the arms industry.
For the purposes of this statement:
- tobacco industry means any entity involved in the manufacture, sale or distribution of tobacco and related products, and any affiliate of such entity; and
- arms industry means any entity involved in the manufacture, sale or distribution of arms, and any affiliate of such entity.
This disclosure statement needs to be provided by any nongovernmental organization, private sector entity, philanthropic foundation and academic institution prior to engaging with WHO.
In view of the foregoing, please answer the following questions:
- Is your entity, or was your entity
over the last four years, part of the tobacco or arms industries
(as defined above)?
- To the best of your entity’s knowledge,
is your entity, or has your entity over the last four years,
engaged in activities that are aimed at furthering or supporting
the interests of the tobacco industry? This includes, but is
not limited to, supply contracts, contract work, services and
lobbying.
- To the best of your entity’s knowledge,
does your entity currently, or did your entity over the last
four years, have any other association or relationship with the
tobacco industry (as defined above). This includes in particular
investment interests (other than general mutual funds or similar
arrangements whereby your entity has no control over the selection
of the investments), commercial business interests, the provision
or receipt of financial and/or other support.
- If you have answered yes to any of the above or are unable to answer one or more questions, please provide a general statement of explanation.
Please note that the WHO Secretariat reserves the right to request additional information from your entity in this regard.
By providing this statement, your entity commits to promptly inform WHO of any change to the above information and to complete a new statement that describes the changes.
HAEMATOLOGY AND HAEMOSTASIS IVD SEGMENT OF HEALTHCARE
LABORATORY HAEMATOLOGY SOCITIES AROUND THE GLOBE
LABORATORY HAEMATOLOGY SOCITIES AROUND THE GLOBE